China Biologic Products Holdings, Inc. (CBPO) Financial Statements (2025 and earlier)
Company Profile
Business Address |
18TH FL, JIALONG INTERNATIONALBUILDING BEIJING, 100125 |
State of Incorp. | |
Fiscal Year End | December 31 |
Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
6/30/2017 Q2 | 3/31/2017 Q1 | 12/31/2016 Q4 | 9/30/2016 Q3 | 6/30/2016 Q2 | 3/31/2016 Q1 | 12/31/2015 Q4 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 197,357 | 183,766 | 203,204 | 204,034 | 180,117 | 182,970 | |||
Cash and cash equivalents | 197,357 | 183,766 | 203,204 | 204,034 | 180,117 | 144,938 | |||
Short-term investments | 38,033 | ||||||||
Receivables | 51,648 | 33,919 | 46,179 | 38,259 | 30,593 | 25,145 | |||
Inventory, net of allowances, customer advances and progress billings | 166,380 | 156,413 | 146,936 | 136,038 | 130,877 | 126,395 | |||
Inventory | 166,380 | 156,413 | 146,936 | 136,038 | 130,877 | 126,395 | |||
Deposits current assets | 1,000 | 1,038 | 4,901 | 10,308 | 10,056 | ||||
Deferred tax assets | 3,954 | 3,225 | |||||||
Other undisclosed current assets | 17,732 | 14,321 | 37,516 | 21,587 | 21,663 | 21,321 | |||
Total current assets: | 433,118 | 393,372 | 434,873 | 404,819 | 373,558 | 369,113 | |||
Noncurrent Assets | |||||||||
Property, plant and equipment | 138,038 | 132,092 | 134,424 | 126,418 | 115,501 | 105,364 | |||
Long-term investments and receivables | 55,065 | 53,860 | 54,540 | 53,820 | 54,974 | 48,552 | |||
Long-term investments | 11,583 | 10,615 | 9,615 | 8,580 | 8,543 | 8,718 | |||
Accounts and financing receivable, after allowance for credit loss | 43,482 | 43,245 | 44,925 | 45,240 | 46,431 | 39,834 | |||
Other noncurrent assets | 5,838 | 2,244 | 2,210 | 2,446 | 3,199 | 4,861 | |||
Deferred tax assets, net | 672 | ||||||||
Other undisclosed noncurrent assets | 23,363 | 22,718 | 24,197 | 24,228 | 24,932 | 23,576 | |||
Total noncurrent assets: | 222,304 | 211,585 | 215,372 | 206,912 | 198,607 | 182,354 | |||
TOTAL ASSETS: | 655,422 | 604,958 | 650,246 | 611,731 | 572,165 | 551,466 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 15,962 | 13,643 | 17,644 | 15,215 | 14,221 | 14,193 | |||
Taxes payable | 9,391 | 7,484 | 10,490 | 8,690 | 8,227 | 4,511 | |||
Accounts payable | 6,570 | 6,159 | 7,155 | 6,526 | 5,995 | 9,682 | |||
Debt | 8,696 | ||||||||
Other undisclosed current liabilities | 59,648 | 59,798 | 54,753 | 49,277 | 42,627 | 57,463 | |||
Total current liabilities: | 84,306 | 73,441 | 72,398 | 64,492 | 56,848 | 71,655 | |||
Noncurrent Liabilities | |||||||||
Liabilities, other than long-term debt | 10,258 | 10,380 | 10,886 | 11,718 | 11,123 | 12,849 | |||
Deferred revenue and credits | 3,655 | 3,756 | 4,026 | 4,180 | 4,420 | 4,526 | |||
Other liabilities | 6,602 | 6,624 | 6,859 | 7,538 | 6,703 | 8,323 | |||
Total noncurrent liabilities: | 10,258 | 10,380 | 10,886 | 11,718 | 11,123 | 12,849 | |||
Total liabilities: | 94,564 | 83,821 | 83,283 | 76,210 | 67,971 | 84,505 | |||
Equity | |||||||||
Equity, attributable to parent | 502,780 | 462,201 | 475,945 | 442,608 | 415,237 | 382,343 | |||
Common stock | 3 | 3 | 3 | 3 | 3 | 3 | |||
Treasury stock, value | (56,425) | (56,425) | (56,425) | (56,425) | (56,425) | (56,425) | |||
Additional paid in capital | 113,630 | 105,460 | 125,123 | 117,265 | 109,649 | 105,080 | |||
Accumulated other comprehensive income (loss) | (22,903) | (25,320) | (11,801) | (8,889) | 2,108 | (19) | |||
Retained earnings | 468,475 | 438,483 | 419,046 | 390,654 | 359,901 | 333,704 | |||
Equity, attributable to noncontrolling interest | 58,078 | 58,936 | 91,017 | 92,912 | 88,957 | 84,619 | |||
Total equity: | 560,858 | 521,137 | 566,962 | 535,520 | 504,193 | 466,962 | |||
TOTAL LIABILITIES AND EQUITY: | 655,422 | 604,958 | 650,246 | 611,731 | 572,165 | 551,466 |
Income Statement (P&L) ($ in thousands)Annual | Quarterly
6/30/2017 Q2 | 3/31/2017 Q1 | 12/31/2016 Q4 | 9/30/2016 Q3 | 6/30/2016 Q2 | 3/31/2016 Q1 | 12/31/2015 Q4 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 91,453 | 77,635 | 86,526 | 91,421 | 85,588 | 68,285 | ||
Cost of revenue | (32,215) | (30,862) | (27,647) | (31,482) | (34,043) | (27,022) | ||
Gross profit: | 59,238 | 46,773 | 58,879 | 59,939 | 51,544 | 41,263 | ||
Operating expenses | (20,422) | (23,510) | (19,156) | (16,904) | (13,650) | (18,291) | ||
Other undisclosed operating loss | (399) | |||||||
Operating income: | 38,816 | 23,263 | 39,723 | 43,035 | 37,894 | 22,573 | ||
Nonoperating income | 2,473 | 4,265 | 2,830 | 1,463 | 1,446 | 957 | ||
Investment income, nonoperating | 1,624 | 2,907 | 1,866 | 1,292 | 1,751 | 1,324 | ||
Interest and debt expense | (63) | (20) | (58) | (89) | (89) | (193) | ||
Income from continuing operations before equity method investments, income taxes: | 41,227 | 27,509 | 42,495 | 44,410 | 39,252 | 23,337 | ||
Income (loss) from equity method investments | 2,519 | (174) | ||||||
Other undisclosed income (loss) from continuing operations before income taxes | 63 | (2,499) | 58 | 89 | 89 | 367 | ||
Income from continuing operations before income taxes: | 41,289 | 27,528 | 42,552 | 44,498 | 39,340 | 23,530 | ||
Income tax expense | (6,951) | (4,348) | (7,164) | (7,007) | (6,607) | (3,201) | ||
Income from continuing operations: | 34,338 | 23,180 | 35,389 | 37,492 | 32,733 | 20,330 | ||
Income before gain (loss) on sale of properties: | 34,338 | 23,180 | 35,389 | 37,492 | 32,733 | 20,330 | ||
Net income: | 34,338 | 23,180 | 35,389 | 37,492 | 32,733 | 20,330 | ||
Net loss attributable to noncontrolling interest | (4,347) | (3,742) | (6,997) | (6,739) | (6,536) | (4,050) | ||
Net income attributable to parent: | 29,992 | 19,438 | 28,391 | 30,753 | 26,197 | 16,280 | ||
Undistributed earnings (loss) allocated to participating securities, basic | ✕ | ✕ | ✕ | ✕ | ✕ | |||
Other undisclosed net loss available to common stockholders, basic | (983) | (673) | (889) | (775) | (648) | (2,071) | ||
Net income available to common stockholders, basic: | 29,009 | 18,765 | 27,503 | 29,978 | 25,549 | 14,209 | ||
Other undisclosed net income available to common stockholders, diluted | 1,657 | |||||||
Net income available to common stockholders, diluted: | 29,009 | 18,765 | 27,503 | 29,978 | 25,549 | 15,866 |
Comprehensive Income ($ in thousands)Annual | Quarterly
6/30/2017 Q2 | 3/31/2017 Q1 | 12/31/2016 Q4 | 9/30/2016 Q3 | 6/30/2016 Q2 | 3/31/2016 Q1 | 12/31/2015 Q4 | ||
---|---|---|---|---|---|---|---|---|
Net income: | 34,338 | 23,180 | 35,389 | 37,492 | 32,733 | 20,330 | ||
Other comprehensive income | 2 | |||||||
Other undisclosed comprehensive income (loss) | 2,721 | (17,062) | (3,544) | (13,267) | 2,568 | (9,273) | ||
Comprehensive income: | 37,059 | 6,118 | 31,845 | 24,224 | 35,303 | 11,057 | ||
Comprehensive loss, net of tax, attributable to noncontrolling interest | (4,651) | (1,214) | (6,366) | (4,469) | (6,979) | (2,396) | ||
Comprehensive income, net of tax, attributable to parent: | 32,409 | 4,905 | 25,479 | 19,756 | 28,324 | 8,661 |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.